Amide Proton Transfer-weighted Imaging of Patients with Alzheimer's Disease

Amide Proton Transfer-weighted Imaging of Patients with Alzheimer's Disease

Background Alzheimer's disease (AD) prevalence is increasing as aging advances worldwide, but its diagnosis is difficult due to atypical early clinical symptoms. Therefore, exploring new and reliable imaging techniques to improve early diagnosis rate of AD has become an important challenge...

Full description

Bibliographic Details
Main Author:	Jingwei LI, Qun LI, Shuo YANG, Zhirong RAN, Mingming ZHENG, Nannan ZHU, Peng CHENG, Yuanyuan CHEN, Li SHI, Xulai ZHANG
Format:	Article
Language:	zho
Published:	Chinese General Practice Publishing House Co., Ltd 2022-08-01
Series:	Zhongguo quanke yixue
Subjects:	alzheimer disease\|magnetic resonance imaging\|nervous system diseases\|aged\|cognition\|correlation of data
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/zx2022010032.pdf

Similar Items

Amide proton transfer imaging of Alzheimer's disease and Parkinson's disease
by: Chunmei Li, et al.
Published: (2023-02-01)

Dysautonomia in Alzheimer’s Disease
by: Delia Tulbă, et al.
Published: (2020-07-01)

Research and progress of focused ultrasound in the treatment of Alzheimer’s disease
by: Xishun Ma, et al.
Published: (2023-12-01)

Technology intervention to support caregiving for Alzheimer’s disease (I-CARE): study protocol for a randomized controlled pilot trial
by: Tyler Braly, et al.
Published: (2021-01-01)

APOE2 is associated with longevity independent of Alzheimer’s disease
by: Mitsuru Shinohara, et al.
Published: (2020-10-01)

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
by: Alhamdu Adamu, et al.
Published: (2024-04-01)

Brain Amide Proton Transfer Imaging of Rat With Alzheimer’s Disease Using Saturation With Frequency Alternating RF Irradiation Method
by: Runrun Wang, et al.
Published: (2019-08-01)

Research progress of microglia causing and promoting Alzheimer's disease
by: WANG Zi-han, LUO Jin-ding, TIAN Ying-ru, FENG Shui-dong, LING Hong-yan
Published: (2021-02-01)

Differential expression of piRNAs in brain from patients with Alzheimer's disease
by: SUN Tian-yi, LIU Fan, QIU Wen-ying, MA Chao
Published: (2021-04-01)

DNA methylation in APOE: The relationship with Alzheimer's and with cardiovascular health
by: Jure Mur, et al.
Published: (2020-01-01)

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
by: Rosalía Fernández-Calle, et al.
Published: (2022-09-01)

Alzheimer's disease : insights into low molecular weight and cytotoxic aggregates from in vitro and computer experiments : molecular basis of amyloid-beta protein aggregation and fibril formation /
by: Derreumaux, Philippe
Published: (2013)

Cholesterol and ApoE in Alzheimer’s disease
by: Potier Marie-Claude, et al.
Published: (2018-07-01)

Value of resting state electroencephalogram in the diagnosis of Alzheimer's disease
by: Zhou Yaxin, et al.
Published: (2023-08-01)

APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
by: Zonghua Li, et al.
Published: (2020-11-01)

Alzheimer's disease : advances in genetics, molecular and cellular biology /
by: Sisodia, Sangram S., et al.
Published: (2007)

Concepts of alzheimer disease : biological, clinical, and cultural perspectives /
by: Whitehouse, Peter J.
Published: (2000)

The Multifaceted Role of WNT Signaling in Alzheimer’s Disease Onset and Age-Related Progression
by: William W. Kostes, et al.
Published: (2023-04-01)

System for early detection of Alzheimer Disease /
by: Ng, Kent Hoo, 1988-, author, et al.
Published: (2012)

System for early detection of Alzheimer Disease /
by: Ng, Kent Hoo, 1988-, author, et al.
Published: (2012)

The contingent valuation method in health care : an economic evaluation of Alzheimers disease /
by: 461120 Nocera, Sandra, et al.
Published: (2003)

Genetic risk and resilience for Alzheimer’s disease: The effect of the three APOE alleles on brain function across life
by: Suri, S
Published: (2016)

Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's disease
by: Sergey Shcherbinin, et al.
Published: (2023-07-01)

Neuropsychological profiles and neural correlates in typical and atypical variants of Alzheimer disease: A systematic qualitative review
by: C. Fredes-Roa, et al.
Published: (2023-07-01)

Mengkaji tentang simptom-simptom dan jenis rawatan atau bantuan bagi penyakit Alzheimer /
by: 359476 Norfaeizah Othman
Published: (2005)

Alzheimer's disease : advances for a new century /
by: Perry, George, editor
Published: (2013)

Correlation between Autonomic Dysfunction and Cognitive Impairment in Patients with Parkinson's Disease
by: DONG Linrui, CHANG Qingqing, MA Jianjun, LIU Chuanze, GUO Dashuai, LI Xiaohuan, FAN Yongyan, LI Dongsheng
Published: (2023-04-01)

Relationship between autonomic nervous function and cognitive function in elderly patients with Parkinson's disease
by: JI Li, et al.
Published: (2024-03-01)

Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
by: Zhuohang Liu, et al.
Published: (2021-07-01)

Exploring the Fermentation-Driven Functionalities of <i>Lactobacillaceae</i>-Originated Probiotics in Preventive Measures of Alzheimer’s Disease: A Review
by: Anjali Tripathi, et al.
Published: (2023-08-01)

Evidence that an <it>APOE </it>ε4 'double whammy' increases risk for Alzheimer's disease
by: Caesar Ina, et al.
Published: (2012-04-01)

Differences in plasma metabolites related to Alzheimer's disease, APOE ε4 status, and ethnicity
by: Badri Vardarajan, et al.
Published: (2020-01-01)

Commentary: Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
by: Patrycja Dzianok, et al.
Published: (2020-05-01)

Melatonin ameliorates microvessel abnormalities in the cerebral cortex and hippocampus in a rat model of Alzheimer’s disease
by: Pan Wang, et al.
Published: (2021-01-01)

Amide Proton Transfer-Weighted MRI Might Help Distinguish Amnestic Mild Cognitive Impairment From a Normal Elderly Population
by: Zixuan Guo, et al.
Published: (2021-10-01)

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
by: Kok Pin Ng, et al.
Published: (2021-01-01)

The Rules of Engagement: Do Microglia Seal the Fate in the Inverse Relation of Glioma and Alzheimer’s Disease?
by: Mathilde Cheray, et al.
Published: (2019-11-01)

Alzheimers disease /
by: 220627 Kelly, Evelyn B.
Published: (2008)

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease
by: Ana-Caroline Raulin, et al.
Published: (2024-02-01)

APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
by: Min Hou, et al.
Published: (2021-02-01)